Fluoxetine and neuroleptic synergistic effects.
Matthews
P
P
Quinn
D
D
Marcoux
G S
GS
Falkenberg
K
K
D000293:Adolescent; D002746:Chlorpromazine / Q000008:administration & dosage / Q000009:adverse effects*; D004200:Diseases in Twins / Q000235:genetics* / Q000523:psychology; D004357:Drug Synergism; D005473:Fluoxetine / Q000008:administration & dosage / Q000009:adverse effects*; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000235:genetics / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000209:etiology
D005473:Fluoxetine; D006220:Haloperidol; D002746:Chlorpromazine